DiaMedica Therapeutics
DMAC
DMAC
58 hedge funds and large institutions have $34.2M invested in DiaMedica Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 57 → 58 (+1)
5% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$8K
Puts
$1K
Top Buyers
| 1 | +$4.23M | |
| 2 | +$1.23M | |
| 3 | +$716K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$651K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$574K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$1.28M | |
| 3 | -$405K | |
| 4 |
Jane Street
New York
|
-$382K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$304K |